Scientech Research’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
Other funds holding IOVA
Scientech Research's IOVA Position: Q2 2026 in Review
Scientech Research reduced its Iovance Biotherapeutics (IOVA) stake by 52% in Q2 2026, selling an estimated $275K and leaving 65,757 shares worth $274K. The position accounts for 0.22% of the portfolio, ranked #125.
Scientech Research first reported a position in IOVA in Q1 2024 and has held it in 6 quarters since. The position peaked at $577K in Q4 2025. 293 funds tracked by Wall St. Rank hold IOVA as of Q2 2026.
- Scientech Research held 65,757 shares of Iovance Biotherapeutics worth $274K as of Q2 2026.
- Scientech Research sold 72,391 Iovance Biotherapeutics shares in Q2 2026, an estimated $275K.
- Iovance Biotherapeutics made up 0.22% of Scientech Research's portfolio in Q2 2026, its #125 holding.
- Scientech Research first reported a position in Iovance Biotherapeutics in Q1 2024 and has held it in 6 quarters since.
- Scientech Research's Iovance Biotherapeutics position peaked at $577K in Q4 2025.
- 293 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2026.
Based on Scientech Research's 13F filing for Q2 2026, filed 14 Aug 2026.